AbTx

AbTx is a preclinical stage biotech company developing the next generation of oncology treatments to treat incurable cancers.
AbTx platform is developing mAb innovative enzymatic conjugation.
Our platform unlock New Frontiers in Medicine to overcome ADC major drawbacks associated targeting solid tumors by generating antibody Fragment Drug Conjugates (FDCs).